FOLD

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Amicus Therapeutics Inc

NASDAQ | FOLD

9.93

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$3.06B

Market Cap

-

P/E Ratio

-0.04

EPS

$10.57

52 Week High

$5.51

52 Week Low

HEALTHCARE

Sector

FOLD Chart

Recent Chart
Price Action

FOLD Technicals

Tags:

FOLD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $475M
Total Revenue $528M
Cost Of Revenue $53M
Costof Goods And Services Sold $53M
Operating Income $25M
Selling General And Administrative $323M
Research And Development $109M
Operating Expenses $450M
Investment Income Net -
Net Interest Income -$44M
Interest Income $5.4M
Interest Expense $50M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5M
Income Before Tax -$29M
Income Tax Expense $27M
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit $21M
Ebitda $29M
Net Income -$56M

Revenue & Profitability

Earnings Performance

FOLD Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $785M
Total Current Assets $505M
Cash And Cash Equivalents At Carrying Value $214M
Cash And Short Term Investments $214M
Inventory $119M
Current Net Receivables $101M
Total Non Current Assets $280M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $17M
Intangible Assets Excluding Goodwill $17M
Goodwill $198M
Investments -
Long Term Investments -
Short Term Investments $36M
Other Current Assets $35M
Other Non Current Assets -
Total Liabilities $591M
Total Current Liabilities $149M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $8.5M
Total Non Current Liabilities $442M
Capital Lease Obligations $54M
Long Term Debt $390M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $444M
Other Current Liabilities $109M
Other Non Current Liabilities $7.1M
Total Shareholder Equity $194M
Treasury Stock -
Retained Earnings -$2.7B
Common Stock $2.9M
Common Stock Shares Outstanding $304M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$34M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.5M
Capital Expenditures $3.6M
Change In Receivables -
Change In Inventory -$74M
Profit Loss -
Cashflow From Investment -$560K
Cashflow From Financing $5.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$56M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $475M
Total Revenue $528M
Cost Of Revenue $53M
Costof Goods And Services Sold $53M
Operating Income $25M
Selling General And Administrative $323M
Research And Development $109M
Operating Expenses $450M
Investment Income Net -
Net Interest Income -$44M
Interest Income $5.4M
Interest Expense $50M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5M
Income Before Tax -$29M
Income Tax Expense $27M
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit $21M
Ebitda $29M
Net Income -$56M

FOLD News

FOLD Profile

Amicus Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Amicus Therapeutics, Inc. (FOLD) is a leading biopharmaceutical company headquartered in Philadelphia, Pennsylvania, specializing in the development of innovative therapies for rare metabolic disorders. With its proprietary enzyme replacement therapy platform, Amicus is at the forefront of personalized medicine, delivering tailored solutions for underserved patient populations. The company's robust pipeline focuses on advancing therapeutics for lysosomal storage disorders, underscoring its commitment to addressing critical unmet needs within the rare disease space and positioning it as a key player in the biotechnology sector.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.84%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.67%
$17.27
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.84%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
APLD
+8.66%
$27.10
NGD
+6.50%
$8.35
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.67%
$17.27
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.